Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149025 · ClinicalTrials.gov registry record · NA
OMT & Intractable Singultus
A NA study, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT07149025: Completed NA study, sponsored by Michigan State University.
NCT07149025 is a NA study that has completed, run by Michigan State University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07149025, a NA study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable Singultus before and after osteopathic manipulative treatment (OMT).
Interventions
- PROCEDURE Osteopathic Manipulative Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
What the finished NCT07149025 record still lists
NCT07149025 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Therapy is the first listed.
NCT07149025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07149025 about?
NCT07149025 is a clinical study titled "OMT & Intractable Singultus". This study plans to use the effects osteopathic manipulative medicine (OMM) techniques to aid in treatment of patients with symptoms of, somatic dysfunction related to, and/or a diagnosis of Intractable Singultus. The aim of our study is to document any changes in associated symptoms of Intractable ...
What is the current status of trial NCT07149025?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-05-01. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT07149025?
The interventions under investigation include: Osteopathic Manipulative Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07149025?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07149025's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI